Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01798810 · ClinicalTrials.gov registry record · NA
Supplemental Perioperative Oxygen to Reduce Surgical Site Infection After High Energy Fracture Surgery
A NA study of Post Operative Surgical Site Infection, sponsored by Major Extremity Trauma Research Consortium.
- Completed
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 2
- Study locations
NCT01798810 is a NA study of Post Operative Surgical Site Infection that has completed, run by Major Extremity Trauma Research Consortium. The registered enrollment target is 1,000 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT01798810, a NA study of Post Operative Surgical Site Infection, has completed, sponsored by Major Extremity Trauma Research Consortium.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The OXYGEN Study is a double blinded prospective randomized controlled trial that will compare the proportion of surgical site infections within 6 months in patients treated with Supplemental Perioperative Oxygen compared to those treated without Supplemental Perioperative Oxygen.
Conditions Studied
Interventions
- PROCEDURE Supplemental Perioperative Oxygen
Study Locations (2)
Arizona
- Banner University Medical Center/The CORE Institute - Phoenix
Maryland
- University of Maryland R Adams Cowley Shock Trauma Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2013-06 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01798810
The ClinicalTrials.gov registry entry for NCT01798810 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Major Extremity Trauma Research Consortium, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post Operative Surgical Site Infection appearing as the primary indexed condition, and to 1 intervention - of which Supplemental Perioperative Oxygen is the first listed.
NCT01798810 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Maryland.
Frequently Asked Questions
What is clinical trial NCT01798810 about?
NCT01798810 is a clinical study titled "Supplemental Perioperative Oxygen to Reduce Surgical Site Infection After High Energy Fracture Surgery". The OXYGEN Study is a double blinded prospective randomized controlled trial that will compare the proportion of surgical site infections within 6 months in patients treated with Supplemental Perioperative Oxygen compared to those treated without Supplemental Perioperative Oxygen.
What is the current status of trial NCT01798810?
This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants. The study started on 2013-06. Estimated completion is 2022-06-30.
What conditions does trial NCT01798810 study?
This clinical trial studies the following conditions: Post Operative Surgical Site Infection.
What interventions are being tested in trial NCT01798810?
The interventions under investigation include: Supplemental Perioperative Oxygen (PROCEDURE).
Who is sponsoring clinical trial NCT01798810?
This trial is sponsored by Major Extremity Trauma Research Consortium, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01798810 being conducted?
This trial has 2 study locations across Arizona, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Operative Surgical Site Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.